UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5351
iShares MSCI Brazil Small-Cap ETF
EWZS
$221M
| $312K | ﹤0.01% |
26,614
+3,043
| +13% | +$40K |
|
|
DMB
5352
BNY Mellon Municipal Bond Infrastructure Fund
DMB
$196M
| $312K | ﹤0.01% |
29,444
-7,715
| -21% | -$78.9K |
|
|
PAI
5353
Western Asset Investment Grade Income Fund
PAI
$114M
| $311K | ﹤0.01% |
25,773
+2,979
| +13% | +$35.7K |
|
5354
Luxfer Holdings
LXFR
$458M
| $311K | ﹤0.01% |
26,823
-1,116
| -4% | -$12.4K |
|
5355
Entrada Therapeutics
TRDA
$267M
| $311K | ﹤0.01% |
21,815
-1,654
| -7% | -$23.5K |
|
5356
Interface
TILE
$2.22B
| $311K | ﹤0.01% |
21,175
-31,016
| -59% | -$482K |
|
5357
Standard BioTools
LAB
$314M
| $311K | ﹤0.01% |
175,536
-308,408
| -64% | -$754K |
|
5358
ADS-TEC Energy
ADSE
$889M
| $310K | ﹤0.01% |
+24,738
| New | +$270K |
|
5359
AdvanSix
ASIX
$444M
| $310K | ﹤0.01% |
13,536
-9,466
| -41% | -$236K |
|
|
SILA
5360
DELISTED
Sila Realty Trust
SILA
| $309K | ﹤0.01% |
+14,611
| New | +$314K |
|
5361
Digimarc Corp
DMRC
$178M
| $309K | ﹤0.01% |
9,960
-10,146
| -50% | -$258K |
|
|
PNNT
5362
Pennant Park Investment Corp
PNNT
$241M
| $309K | ﹤0.01% |
40,907
+9,778
| +31% | +$71K |
|
5363
Entera Bio
ENTX
$141M
| $308K | ﹤0.01% |
167,623
+17,754
| +12% | +$38.9K |
|
|
MBCN
5364
DELISTED
Middlefield Banc Corp
MBCN
| $308K | ﹤0.01% |
12,821
-6,273
| -33% | -$140K |
|
5365
Weyco Group
WEYS
$440M
| $308K | ﹤0.01% |
10,165
-3,992
| -28% | -$118K |
|
5366
Anterix
ATEX
$1.94B
| $308K | ﹤0.01% |
7,773
-6,873
| -47% | -$222K |
|
5367
Columbia Financial
CLBK
$1.13B
| $308K | ﹤0.01% |
20,553
-19,041
| -48% | -$295K |
|
5368
PUT
Jacobs Solutions
J
$17B
| $307K | ﹤0.01% |
+2,660
| New | +$312K |
|
5369
FlexShares iBoxx 3-Year Target Duration TIPS Index Fund
TDTT
$2.53B
| $307K | ﹤0.01% |
13,028
-14,641
| -53% | -$344K |
|
5370
ProShares MSCI EAFE Dividend Growers ETF
EFAD
$64.5M
| $306K | ﹤0.01% |
8,111
+3,717
| +85% | +$142K |
|
|
TPZ
5371
Tortoise Electrification Infrastructure ETF
TPZ
$124M
| $306K | ﹤0.01% |
19,357
-426
| -2% | -$6.56K |
|
|
CAN
5372
Canaan Creative
CAN
$159M
| $304K | ﹤0.01% |
304,315
-28,969
| -9% | -$30.5K |
|
5373
CALL
Affirm
AFRM
$25.2B
| $303K | ﹤0.01% |
+10,040
| New | +$322K |
|
5374
Preformed Line Products
PLPC
$2.28B
| $303K | ﹤0.01% |
2,434
-1,467
| -38% | -$187K |
|
|
JF
5375
J and Friends Holdings
JF
$17.7M
| $302K | ﹤0.01% |
283,603
+142,328
| +101% | +$153K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.